Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Axonics, Inc.

Axonics, Inc. (AXNX) Stock Overview

Explore Axonics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AXNX●NASDAQ
HealthcareMedical - Devices
$70.98
$0.00(0.00%)
U.S. Market opens in 3h 2m

Axonics, Inc. (AXNX)

Meyka AI Score

Z

Key Financials

Market Cap3.6B
P/E Ratio-591.50
EPS (TTM)$-0.10
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$70.74

AXNX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Axonics, Inc. (NASDAQ: AXNX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Axonics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AXNX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $70.74 for the NASDAQ listing.

Key metrics behind Axonics, Inc.'s NASDAQ-traded stock include a P/E ratio of -591.50 and a market capitalization of 3.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AXNX on the NASDAQ.

Price Performance (NASDAQ: AXNX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
3.12%
6-Month Change
5.63%
Year-to-Date (YTD) Change
18.87%
1-Year Change
19.25%
3-Year Change
41.56%
5-Year Change
174.58%
All-Time (Max) Change
373.83%

Contact Information

https://www.bostonscientific.com/en-US/home.html
949 396 6322
26 Technology Drive, Irvine, CA, 92618

Company Facts

7,970 Employees
IPO DateOct 31, 2018
CountryUS

Frequently Asked Questions